Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04536142 · ClinicalTrials.gov registry record
Evaluation of Changes in Brain Connectivity After Tumor Resection
A clinical trial, sponsored by University of Nebraska.
- Completed
- Registry status
- 43
- Enrollment target
NCT04536142: Completed study, sponsored by University of Nebraska.
NCT04536142 is a clinical trial that has completed, run by University of Nebraska. The registered enrollment target is 43 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04536142 has completed, sponsored by University of Nebraska.
- COMPLETED
- Registry status
- 43 participants
- Enrollment target
Study Summary
This study is being done to see the changes in structural and functional connectivity that happen in the brain of patients undergoing brain tumor surgery.
Primary Outcome
With both the functional and structural connectomes created, the investigators will compute graph network measures before and after surgical resection and assess both nodal and global network measures.
Interventions
- DIAGNOSTIC_TEST MRI
- DIAGNOSTIC_TEST neuropsychological tests and qualitative assessment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 43 participants |
| Start Date | 2020-08-27 |
| Est. Completion | 2023-06-06 |
What the finished NCT04536142 record still lists
NCT04536142 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 43 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which MRI is the first listed.
NCT04536142 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04536142 about?
NCT04536142 is a clinical study titled "Evaluation of Changes in Brain Connectivity After Tumor Resection". This study is being done to see the changes in structural and functional connectivity that happen in the brain of patients undergoing brain tumor surgery.
What is the current status of trial NCT04536142?
This trial is currently completed. The enrollment target is 43 participants. The study started on 2020-08-27. Estimated completion is 2023-06-06.
What interventions are being tested in trial NCT04536142?
The interventions under investigation include: MRI (DIAGNOSTIC_TEST), neuropsychological tests and qualitative assessment (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04536142?
This trial is sponsored by University of Nebraska, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03726359 · 43 participants · Phase 1
Phase I Study of Fractionated Stereotactic Radiation Therapy
- NCT03850418 · 43 participants · Phase 2
Azacitidine and Chimerism in MDS or AML Patients After Allogeneic Stem Cell Transplant
- NCT04144023 · 43 participants · Phase 1
A Vaccine (H2NVAC) Before Surgery for the Treatment of HER2-Expressing Ductal Carcinoma In Situ
- NCT04176718 · 43 participants · Phase 2
Daratumumab, Carfilzomib, Pomalidomide, Dexamethasone In MM
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI